Christopher Y. Caughman

Christopher Caughman practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Christopher Caughman's NPI, 1659768109, was assigned on April 22, 2015. Christopher Caughman holds Georgia license 83202.

Christopher Caughman's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Christopher Caughman's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Christopher Caughman is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Christopher Caughman to 5 more hospitals, 2 therapy and rehab clinics, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Caughman practices, 10 sites in all. Vendor and product names are available with a free account.

Neurology is Christopher Caughman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Christopher Caughman is licensed in Georgia.

CMS data shows 8,531 Medicare services from Christopher Caughman across 8 procedure codes in 2024, for 512 Medicare patients. Medicare paid $115,253 for them. Every service was in an office.

CMS counts 512 Medicare patients who saw Christopher Caughman in 2024. The largest group is 75 to 84, with 253 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Caughman's median patient age at 75, with 47% women.

In 2024, Christopher Caughman wrote 3,237 Medicare Part D claims for 607 patients. 93% of them were for generic drugs. CMS names the drug for 3,014 of them, across 31 drugs with 11 or more claims each, at $817,391 in total drug cost. In 2023, CMS named 2,723 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Christopher Caughman for performance year 2024, reported through an alternative payment model (APM). Christopher Caughman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Caughman as offering telehealth.

Dmand AI links 2 papers to Christopher Caughman, published from 2012 to 2020. Christopher Caughman's most frequent co-authors are Stewart A. Factor, DO and Aimee S. Payne, MD, PhD.

CMS Open Payments shows 3 general payments to Christopher Caughman from 3 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $30.